N2-iso-Butyryl-8-azaguanosine
N2-iso-Butyryl-8-azaguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
2328168-83-6
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/n2-iso-butyryl-8-azaguanosine.html
Solubility
10 mM in DMSO
Smiles
O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N2C(N=C(NC(C(C)C)=O)NC3=O)=C3N=N2
Molecular Formula
C13H18N6O6
Molecular Weight
354.32
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ACTH (Adrenocorticotrophic Hormone) (AH26), CF647 conjugate, 0.1mg/mL
Cytokeratin 17 (E3), CF647 conjugate, 0.1mg/mL
CD59 (heavy chain of Protectin) (BRA-10G), CF405S conjugate, 0.1mg/mL
Fibronectin (HFN7.1), CF568 conjugate, 0.1mg/mL
Bcl-2 (BCL2/782 + BCL2/796), CF594 conjugate, 0.1mg/mL
